Highly Efficient in Vivo Cancer Therapy by an Implantable Magnet Triboelectric Nanogenerator

Chaochao Zhao,Hongqing Feng,Lijun Zhang,Zhe Li,Yang Zou,Puchuan Tan,Han Ouyang,Dongjie Jiang,Min Yu,Chan Wang,Hu Li,Lingling Xu,Wei,Zhou Li
DOI: https://doi.org/10.1002/adfm.201808640
IF: 19
2019-01-01
Advanced Functional Materials
Abstract:In this work, a nanogenerator-controlled drug delivery system (DDS) for use in cancer therapy is successfully established. A new magnet triboelectric nanogenerator (MTENG) is fabricated that can guarantee the contact and detach cycle between the two friction layers and effectively increase the TENG output, up to 70 V after implantation. Using a special structural design, without the commonly used spacer, this contacting-mode MTENG can ensure a high and consistent electricity output after encapsulation and implantation. Doxorubicin-(DOX-) loaded red blood cells (RBCs) are employed as the anti-tumor DDS in this study. After DOX loading, the RBC membranes are stable and the self-release is very slow. However, upon electric stimulation from the MTENG, the release of DOX is remarkably increased, and falls back to normal again after the stimulation. Thus a controllable DDS is established. The MTENG-controllable DDS achieves an outstanding killing of carcinomatous cells both in vitro and in vivo at a low DOX dosage. These results demonstrate a prominent therapeutic effect of the MTENG-controlled DDS for cancer therapy, which is highly promising for application in the clinic.
What problem does this paper attempt to address?